Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06296849 · ClinicalTrials.gov registry record · NA
Dyadic Financial Incentive Treatments for Dual Smoker Couples
A NA study of Smoking, Cigarette, sponsored by University of Georgia.
- Recruiting
- Registry status
- NA
- Development phase
- 900
- Enrollment target
- 1
- Study location
NCT06296849: Recruiting NA study of Smoking, Cigarette, sponsored by University of Georgia.
NCT06296849 is a NA study of Smoking, Cigarette that is actively recruiting participants, run by University of Georgia. The registered enrollment target is 900 participants, above the 491-participant average among 21 other Smoking, Cigarette trials with a reported enrollment target (83% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06296849, a NA study of Smoking, Cigarette, is actively recruiting participants, sponsored by University of Georgia.
- RECRUITING
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
- 1
- Study location
Study Summary
Smokers partnered with other smokers (i.e., dual-smoker couples) represent \~2/3 of all smokers. Dual-smoker couples (DSCs) are less likely to try to quit smoking and more likely to relapse during a quit attempt, reducing overall smoking cessation rates and representing a high-risk clinical population. Despite their high prevalence and risk for persistent smoking, however, there are limited data on smoking cessation interventions among DSCs. Building on previous research that suggests a) financial incentive treatments (FITs) are effective at increasing quit rates and b) dyadic adaptations of FITs are feasible for implementation in DSCs, the proposed study will systematically two versions of FITs to enhance smoking cessation among DSCs. In addition to determining the efficacy of these dyadic FITs for smoking abstinence in DSCs, the investigators will consider the cost and cost effectiveness of each adaptation as well as mechanisms of change to inform future implementation research. The investigators will additionally consider secondary outcomes including abstinence during treatment and long-term abstinence maintenance after end of treatment. The investigators will address these questions in a three-group randomized controlled trial (RCT). In all conditions, individuals who have smoking partners (i.e., targets) will receive usual care (combination fast and slow acting Nicotine Replacement Therapy + quitting resources). In two conditions, participants will receive incentives for abstinence at three time points (1, 3, and 6 months post-baseline). In the SFIT condition, only the target in a couple will be offered incentives; in the DFIT condition, both target and partner will be offered incentives. Primary efficacy outcome is % point-prevalence abstinence at 6 months post-baseline among targets. Secondary outcomes are point-prevalence abstinence at 1 and 3 months during the treatment and 6 months post-treatment (12-months post-baseline), as well as partner outcomes. The
Primary Outcome
% of targets (intent to treat sample) who are abstinent (self-report no smoking past 7 days + expired carbon monoxide (CO) \<= 5 ppm
Conditions Studied
Interventions
- BEHAVIORAL Financial Incentive Treatment (FIT)
Study Locations (1)
Georgia
- University of Georgia - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2028-05 |
| Phase | NA |
What NCT06296849 shows while recruiting
NCT06296849 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 491-participant average among 21 other Smoking, Cigarette trials with a reported enrollment target (83% higher).
The record links to 1 condition, with Smoking, Cigarette appearing as the primary indexed condition, and to 1 intervention - of which Financial Incentive Treatment (FIT) is the first listed.
NCT06296849 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06296849 about?
NCT06296849 is a clinical study titled "Dyadic Financial Incentive Treatments for Dual Smoker Couples". Smokers partnered with other smokers (i.e., dual-smoker couples) represent \~2/3 of all smokers. Dual-smoker couples (DSCs) are less likely to try to quit smoking and more likely to relapse during a quit attempt, reducing overall smoking cessation rates and representing a high-risk clinical populati...
What is the current status of trial NCT06296849?
This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2024-01-18. Estimated completion is 2028-05.
What conditions does trial NCT06296849 study?
This clinical trial studies the following conditions: Smoking, Cigarette.
What interventions are being tested in trial NCT06296849?
The interventions under investigation include: Financial Incentive Treatment (FIT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06296849?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06296849 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking, Cigarette
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06296849's enrollment target sits among peer trials
900 3rd of 21 higher than 19 of 21 other Smoking, Cigarette trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking, Cigarette trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
RECRUITING · NA
-
Optimizing Tobacco Treatment Delivery for People Living With HIV
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
Maternal Smoking Cessation and Pediatric Obesity Prevention
RECRUITING · NA
-
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI